KeyBanc lowered the firm’s price target on Corteva (CTVA) to $68 from $69 and keeps an Overweight rating on the shares. The firm struggles to identify concrete reasons for optimism for 2025 in Chemicals, and sees more uncertainty around 2025 for chemicals than in 2024, including FX headwinds, tariffs, uneven autos and housing, and the risk of labor and materials inflation, the analyst tells investors in a research note. In commodities, given persistent overcapacity, the firm does not see margins meaningfully improving over the next 12 months.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTVA:
Questions or Comments about the article? Write to editor@tipranks.com